Child neurology telemedicine: Analyzing 14 820 patient encounters during the first year of the COVID-19 pandemic.
Publication/Presentation Date
3-1-2023
Abstract
AIM: To determine the long-term impact of telemedicine in child neurology care during the COVID-19 pandemic and with the reopening of outpatient clinics.
METHOD: We performed an observational cohort study of 34 837 in-person visits and 14 820 telemedicine outpatient visits across 26 399 individuals. We assessed differences in care across visit types, time-period observed, time between follow-ups, patient portal activation rates, and demographic factors.
RESULTS: We observed a higher proportion of telemedicine for epilepsy (International Classification of Diseases, 10th Revision G40: odds ratio [OR] 1.4, 95% confidence interval [CI] 1.3-1.5) and a lower proportion for movement disorders (G25: OR 0.7, 95% CI 0.6-0.8; R25: OR 0.7, 95% CI 0.6-0.9) relative to in-person visits. Infants were more likely to be seen in-person after reopening clinics than by telemedicine (OR 1.6, 95% CI 1.5-1.8) as were individuals with neuromuscular disorders (OR 1.6, 95% CI 1.5-1.7). Self-reported racial and ethnic minority populations and those with highest social vulnerability had lower telemedicine participation rates (OR 0.8, 95% CI 0.8-0.8; OR 0.7, 95% CI 0.7-0.8).
INTERPRETATION: Telemedicine continued to be utilized even once in-person clinics were available. Pediatric epilepsy care can often be performed using telemedicine while young patients with neuromuscular disorders often require in-person assessment. Prominent barriers for socially vulnerable families and racial and ethnic minorities persist.
Volume
65
Issue
3
First Page
406
Last Page
415
ISSN
1469-8749
Published In/Presented At
Kaufman, M. C., Xian, J., Galer, P. D., Parthasarathy, S., Gonzalez, A. K., McKee, J. L., Prelack, M. S., Fitzgerald, M. P., Helbig, I., & CHOP Neuroscience Center ‐ Telemedicine Research Group (2023). Child neurology telemedicine: Analyzing 14 820 patient encounters during the first year of the COVID-19 pandemic. Developmental medicine and child neurology, 65(3), 406–415. https://doi.org/10.1111/dmcn.15406
Disciplines
Medicine and Health Sciences | Pediatrics
PubMedID
38767061
Department(s)
Department of Pediatrics
Document Type
Article